De-Risk Regulatory Submissions Through
Smarter LNP Characterization

pfizer - 3rd LNP Characterization & Analytical Development Summit
prime medicine - 3rd LNP Characterization & Analytical Development Summit
astrazeneca - 3rd LNP Characterization & Analytical Development Summit
Tessera Therapeutics - 3rd LNP Characterization & Analytical Development Summit
GSK - 3rd LNP Characterization & Analytical Development Summit
Beam Therapeutics - 3rd LNP Characterization & Analytical Development Summit
Genentech - 3rd LNP Characterization & Analytical Development Summit
Eli Lilly - 3rd LNP Characterization & Analytical Development Summit
Regeneron - 3rd LNP Characterization & Analytical Development Summit

Leverage Robust LNP Analytical Methods to Generate Reproducible Data, Ensure Product Consistency & Accelerate Confident Regulatory Submissions to Support Genetic Medicine Approvals

LNPs continue to dominate as the non-viral delivery vehicle of choice given their ability to encapsulate fragile payloads, such as mRNA, siRNA, gRNA and more, and deliver them into target cells with high efficacy. However, critical challenges remain in assessing targeted LNP surface functionalization, evaluating encapsulation efficiency for multivalent formulations, and aligning analytical results with process performance.

 

The 3rd LNP Characterization & Analytical Development Summit is the only global event dedicated to this specialized field, providing analytical experts with in-depth technical insights into accelerating development timelines, overcoming analytical gaps and streamlining regulatory submissions for fast-tracking approval of high-quality LNP drug products.

 

Join experts from Pfizer, Novo Nordisk, Prime Medicine, Tessera Therapeutics, GSK, Sanofi, and more as we explore the cutting edge of LNP characterization and analytics. Don’t miss this opportunity to collaborate with the brightest minds shaping the future of LNP drug development.

I have attended every year’s LNP Characterization & Analytical Development Summit since its inauguration and learned from my industry and academic peers every year. It is a great opportunity for people working in this field to meet and share insights with each other, and I look forward to attending the summit again this year

Zack Zhang, Director, Analytical Research & Development,
Beam Therapeutics

Beam Therapeutics - 3rd LNP Characterization & Analytical Development Summit

Our Industry-Leading Speakers:

What to Expect:

90+

Attendees from ​Large Pharma, Innovative Biotech & Academia

24+

Expert Speakers at the Forefront of LNP Analytical Development

16+

Data-Driven Sessions

8+

Hours of Dedicated Networking Sessions 

6+

Deep Dive Workshops & Interactive Discussion Sessions

Opportunities for Networking & Knowledge Sharing

Our Partners:

explore the agenda LNP

Explore the Agenda

Experience a jam-packed agenda featuring the latest analytical advancements for targeted and multivalent LNPs, along with exclusive insights into cutting-edge characterization strategies for evaluating LNP size, morphology, and biodistribution

partner with us lnp

Partner With Us

Position yourself alongside other leading analytical and assay solution providers to ensure your brand is at the heart of LNP deals and collaborations

 

 

join experts lnp

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all a wide variety of analytical strategies for advancing LNP drug products, and make critical connections during our dedicated networking sessions
s